Kymera Therapeutics (NASDAQ:KYMR) Director Sells 134,720 Shares
MarketBeat
Kymera Therapeutics, Inc. (NASDAQ:KYMR - Get Free Report) Director Bruce Booth sold 134,720 shares of Kymera Therapeutics stock in a transaction that occurred on Wednesday, June 24th. The shares were sold at an average price of $100.51, for a total transaction of $13,540,707.20. Following the sale, the director directly owned 597,047 shares in the company, valued at $60,009,193.97. This trade represents a 18.41% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
NASDAQ:KYMR